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Abstract
Objective
Characterization of Staphylococcus aureus clinical isolates derived from lower respiratory
tract infections (LRTIs), and correlation between the functionality of the accessory gene reg-
ulator (Agr) and genotypic and phenotypic characteristics, clinical variables and clinical
outcome.
Methods
S aureus isolates derived from LRTIs and control groups (nasal carriage and bacteraemia)
were genotyped using StaphyType DNA microarray. Agr activity was evaluated using the
CAMP synergistic haemolysis assay and the Vesicle Lysis Test (VLT). Discordant strains
were analysed by quantitative reverse-transcriptase real-time PCR (qRT-PCR).
Results
Agr was functional in 79.7% and 84.5% of strains according to the CAMP and VLT assays
respectively. Higher concordance with RNAIII expression measured by qRT-PCR was
observed with the VLT assay (76.2%) compared with the CAMP assay (23.8%). No statisti-
cally significant differences were observed in Agr functionality between the study groups,
nor the phenotypical/genotypical bacterial characteristics. No association between
increased mortality/respiratory complications and Agr function was observed.
Conclusions
Agr activity was high (82.2%) in isolates from LRTIs suggesting the importance of this global
regulator in lower respiratory tract colonisation and infection. However, equally high Agr
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activity was observed in isolates derived from nasal carriage and bacteraemia, contradictory
to previous observations. Agr functionality measured by the VLT assay was superior to
CAMP assay.
Introduction
Staphylococcus aureus is a commensal and an opportunistic pathogen, described as the causa-
tive agent in a wide range of human infections [1]. Although bloodstream and skin and soft-
tissue infections represent the major burden of staphylococcal disease, lower respiratory tract
infections (LRTI) by S. aureus have been increasing in the hospital setting [2, 3]. However, bac-
terial colonisation of the respiratory environment is known [4], making the distinction
between asymptomatic colonization and infection difficult [5].
In order to establish and maintain infection, S. aureus utilizes an arsenal of virulence fac-
tors, which vary depending on its growth phase. The accessory gene regulatory (Agr) system is
one of the most important and well-characterised operons in S. aureus biology, central in the
control and regulation of virulence gene expression [6–9]. The operon is autocatalytic, con-
trolled in a cell density-dependent fashion through the production and sensing of auto-induc-
ing peptides (AIP). The Agr locus consists of two divergent transcripts, RNAII and RNAIII,
driven by two promoters, P2 and P3 respectively. Activation of the P2 promoter drives the
expression of the components of the quorum-sensing system (AgrBDCA). AgrB and D com-
bine to process and secrete the AIP, which in turn acts as the ligand binding to the AgrC recep-
tor [10]. AgrC and AgrA function as a classical two-component signal transduction system
where activated AgrC phosphorylates the DNA-binding response regulator, AgrA, leading to
dimerization and binding to the intergenic region between P2 and P3 promoters upregulating
their expression [8]. Expression from the P3 promoter drives the synthesis of RNAIII, a highly
abundant RNA effector molecule which also contains the 26 amino acid delta (δ)- haemolysin
[11]. During post exponential growth, RNAIII acts reciprocally, mediating a switch from the
expression of surface proteins such as protein A (SpA) to toxins and enzymes such as alpha
haemolysin and proteases [11]. Airway colonization by S. aureus is a precursor for the develop-
ment of LRTI, however little is known about the pathogen-associated factors that promote pro-
gression from colonization to LRTI [12]. It has been widely documented that a functional Agr
is central for causing disease in animal models of infection [13–15]. However, numerous
reports suggest that the role of Agr in human infection is more complex, compounded by the
isolation of Agr dysfunctional strains from clinical samples [16–21]. Agr dysfunction has been
associated with persistent bacteraemia, decreased susceptibility to vancomycin and thrombin-
induced platelet microbicidal protein [16, 19]. Agr dysfunctional strains generally have a
higher biofilm capacity and are more fit in vitro due to the large metabolic burden of having an
active Agr system [22, 23].
Both qualitative and quantitative methods can be employed to evaluate Agr activity. The
classical method of measuring Agr is via the CAMP assay, which utilises the expression of
delta toxin as a surrogate for RNAIII and thus Agr function. This method relies on the syner-
gistic haemolysis of red blood cells by delta toxin in conjunction with beta-toxin [24, 25].
Despite the straightforward handling of this assay, the interpretation of results can be subjec-
tive due to low sensitivity [17]. Recently, analytical techniques such as Whole-Cell Matrix
Assisted Laser Desorption Ionization-Time-of-Flight (MALDI-TOF) mass spectrometry [26,
27] and high-performance liquid chromatography (HPLC) [28] have been successfully used to
Agr activity in respiratory derived S.aureus isolates
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detect delta-toxin and evaluate Agr status. While both of these techniques are highly sensitive,
their use for Agr evaluation has not been used frequently possibly due to high purchase costs.
Detecting and quantifying Agr at the transcript level using probes (Northern blotting) or prim-
ers (quantitative reverse transcriptase-PCR (qRT-PCR)) directed against RNAIII has been
used extensively [11, 29, 30]. Although both of these techniques are considerably more sensi-
tive than CAMP, both are time consuming, laborious and expensive. A new method, the Vesi-
cle Lysis Test (VLT), employing phospholipid vesicles containing self-quenched fluorescent
dye which are specific to delta and phenol-soluble modulin toxins, acting as surrogates as
RNAIII and RNAII activity has been developed [31]. Based on the current literature we
decided to include the CAMP assay, as this is the conventional assay performed. In parallel, we
chose to use the VLT assay as this was illustrated to be fast, highly sensitive and amenable to
high-throughput. Due to the high sensitivity of qRT-PCR we chose to use this assay to evaluate
Agr activity in discordant strains.
Based on the complex relationship between Agr and human infection and the lack of
understanding of factors associated with S aureus LRTIs, the objectives of this study were two-
fold. 1) To evaluate Agr function in clinical S. aureus isolates derived from LRTIs and control
groups (nasal carriage and bacteraemia); and 2) to investigate correlations between Agr func-
tionality and strain’s genotypic and phenotypic characteristics, clinical variables and clinical
outcome.
Materials and methods
Study groups and bacterial strains
S. aureus isolates included in this study were retrospectively selected from a strain collection at
the Hospital Universitari Germans Trias i Pujol, a tertiary care hospital in Badalona, Spain.
These isolates were obtained from intensive care unit (ICU) and non ICU patients presenting
LRTIs as well as from adult nasal carriers and patients presenting bacteraemia, both represent-
ing control groups (Table 1). Ethical approval was provided by the Institutional Review Board:
Comitè d’ E`tica de la Investigacio´ de l’Hospital Germans Trias i Pujol. Study was performed
according to confidentiality criteria and dissociation of patients’ identification data. Patient
informed consent was not needed because clinical samples were not analyzed. Only clinical
strains isolated during routine diagnostic tests were used, and were irreversible dissociated in
order to guarantee confidentiality. All isolates were obtained from primary cultures and stored
at—80˚C in maintenance freeze medium (Oxoid TP, 15731) until required to minimise
Table 1. Distribution of methicillin resistance, Agr functionalitya and Agr allele according to the study group considered.
Study group (n) MRSA (%) Agr Functionalitya, n (%) Allele agr, n (%)
Positive Negative I II III IV
Pneumonia (22) 4 (18.2) 19 (86.4) 3 (13.6) 10 (45.5) 9 (40.9) 2 (9.1) 1 (4.5)
Tracheobronchitis (35) 8 (22.9) 27 (77.1) 8 (22.9) 15 (42.9) 14 (40.0) 5 (14.3) 1 (2.9)
Bronchial Colonization (29) 7 (24.1) 25 (86.2) 4 (13.8) 11 (37.9) 13 (44.8) 4 (13.8) 1 (3.4)
Other LRTI (9)b 3 (33.3) 7 (77.8) 2 (22.2) 5 (55.6) 4 (44.4) 0 (0) 0 (0)
Carriage (35) 2 (5.7) 29 (82.9) 6 (17.1) 13 (37.1) 7 (20.0) 15 (42.9) 0 (0)
Bacteraemia (18) 1 (5.6) 15 (83.3) 3 (16.7) 7 (38.9) 4 (22.2) 7 (38.9) 0 (0)
Total (148) 25 (16.8) 122 (82.4) 26 (17.6) 61 (41.2) 51 (34.5) 33 (22.3) 3 (2.0)
a Agr functionality determined through CAMP, VLT and discordant strains resolved by qRT-PCR.
b Other LRTI include: Pneumonitis: 1 strain; Bronchoaspiration pneumonia: 3 strains; Tracheostomy infection: 5 strains.
https://doi.org/10.1371/journal.pone.0175552.t001
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mutations that may affect Agr activity [17]. Strains were phenotypically characterized by con-
ventional identification (Gram stain, selective culture media, coagulase test) and antibiotic sus-
ceptibility testing was routinely performed using the standard disk diffusion method and
interpreted according to the Clinical and Laboratory Standards Institute. Strains were geno-
typically characterised and Agr activity was evaluated using the classical CAMP synergistic
haemolysis test [17], the Vesicle Lysis Test [31] and by using real time quantitative reverse
transcriptase -PCR (Real time qRT-PCR).
Clinical definitions
Patients with LRTIs admitted to the ICU were classified according to Clinical Pulmonary
Infection Score (CPIS) [32], into: bronchial colonization, tracheobronchitis or pneumonia.
Other LRTI included isolates from patients presenting bronchial aspiration, tracheostomy
infection and pneumonitis. Persistent respiratory isolation/bacteremia was considered as 72
hours positive cultures after patients received adjusted antibiotic treatment. Respiratory com-
plications for patients with LRTIs were defined as respiratory failure, atelectasis, empyema,
pleural effusion, pneumothorax, reinfection or shock.
Agr CAMP assay
The conventional method used to determine the Agr functionality is via δ-haemolysin produc-
tion. Agr functionality was determined by cross-streaking S. aureus isolates perpendicularly to
RN4220 on sheep blood agar (SBA, Oxoid, UK). RN4220 is a S. aureus strain that produces a
large zone of β-haemolysin without the interference of α- or δ-haemolysin. Plates were incu-
bated at 37˚C overnight followed by a 24 h incubation at 4˚C after which they were docu-
mented. The presence of synergistic haemolysis within the β-haemolysin zone indicates the
production of δ-haemolysin and, therefore, a functional Agr locus. In contrast, Agr dysfunction
was defined as the complete absence of δ-haemolysin within the β-haemolysin zone. In order
to establish the final result, three different observers analysed the photographs, and the pres-
ence or absence of δ-haemolysin was determined by consensus, according to Traber et al [17].
Vesicle lysis test
S. aureus isolates were streaked onto tryptic Soy agar (TSA) and single colonies were trans-
ferred to 5 mL tryptic soy broth (TSB) and grown in a shaking incubator (180 rpm) for 18 h at
37˚C. 1 mL of culture was harvested and centrifuged at 14000 × g for 10 min, and 500 μL of
supernatant were recovered, stored at -20˚C and lyophilized. These steps were performed in
triplicate. The protocol for vesicle formulation has been described previously [31]. For the
Vesicle Lysis Test (VLT), the lyophilized supernatants were resuspended with 500 μL of molec-
ular grade water and a 50 μL aliquot was incubated with 50 μL of vesicle solution. Positive and
negative controls were pure vesicles with 0.01% Triton X-100 and HEPES, respectively. The
fluorescence intensity of each sample was measured for 30 min at excitation and emission
wavelengths of 485–520 nm, respectively, on a FLUOROstar fluorimeter (BMG Labtech, UK).
Normalized fluorescence was achieved using the equation (Ft-F0)/(Fm/F0), where Ft is the
average fluorescence value at a specific time point, F0 is the minimum and Fm is the maximum
fluorescence value in that particular experiment.
Reverse transcription and quantitative RT-PCR
S. aureus isolates grown overnight in TSB were diluted 1:1000 in fresh TSB and grown at 37˚C
for 6 h. Cultures were normalised based on OD600 measurements prior to RNA isolation.
Agr activity in respiratory derived S.aureus isolates
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Cultures were treated with two volumes of RNAprotect (Qiagen, USA) incubated for 10 min at
room temperature, centrifuged at 3000 × g and the pellet was resuspended in Tris-EDTA (TE)
buffer (Ambion, USA) with lysostaphin (Cell sciences, Canada) (250 μg/mL) and incubated
for 1 h, followed by proteinase K treatment for 30 min. RNA was isolated using the RNeasy
Mini Kit (Qiagen, USA) according to the manufacturer’s instructions with the addition of
turbo DNase (Ambion, USA) following the purification step. RNA was quantified using RNA
BR kit (Qubit, ThermoFisher Scientific, UK) and the absence of DNA was verified by PCR.
Reverse transcription was performed using the QuantiTect reverse transcription system (Qia-
gen, USA) according to manufacturer’s instructions. Standard curves were generated for both
gyrase B [gyrFW:5’-CCAGGTAAATTAGCCGATTGC-3’; gyrRV:5’- AAATCGCCTGCGTTC
TAGAG] and RNAIII primers [rnaIIIFW: 5’- GAAGGAGTGATTTCAATGGCACAAG-3’;
rnaIIIRV: 5’ GAAAGTAATTAATTATTCATCTTATTTTTTAGTGAATTTG-3’] using genomic
DNA to determine primer efficiency. Real-time PCR was performed using the SYBR green
PCR master mix (Applied Biosystems, Thermo Fisher Scientific, USA) and the Step-One Real
Time PCR detection system (Applied Biosystems, Thermo Fisher Scientific, USA). Cycling
conditions were 95˚C for 10 min followed by 40 cycles of 95˚C for 15 s and 60˚C for 1 min and
a dissociation step 95˚C for 15 s and 60˚C for 1 min. Quantities derived from standard curves
were determined for 2 biological repeats and relative expression normalised to the value of the
positive control (RN6390B). We determined a strain to be Agr functional with RNAIII expres-
sion levels determined to be a minimum of within 10-fold of the positive control. Isolates that
had less than 10-fold level of the positive control after sampling at 6h were classified as Agr
dysfunction, based on previous findings determining delayed RNAIII expression and Agr dys-
function [17, 33].
Agr functionality was categorized into positive/ negative by CAMP, VLT and/ or qRT-PCR.
Genotypic characterization
S. aureus isolates were genotypically characterised using the StaphyType DNA microarray
(Alere Technologies, Jena, Germany) [34, 35]. The Microtiter strip-mounted DNA microar-
rays used covered 334 target sequences (approximately 170 distinct genes and their allelic
variants). PCR amplification and hybridization were performed following manufacturer’s
instructions. An image of the array was recorded and analysed using a designated reader and
software (Arraymate, Iconoclust, Alere Technologies) [36].
Statistical analysis
Pearson’s chi-square or Fisher test was applied when comparing categorical clinical and micro-
biological variables. Kappa (k) values below 0.40 indicate weak correlation, values of 0.41–0.60
indicate good agreement and values above 0.60 indicate strong agreement. Univariate and
multivariate analysis as well as a logistic regression model were performed.
Associations were considered statistically significant if p value was <0.05. Data was ana-
lysed with SPSS v15 (SPSS Inc, Chicago, IL).
Results
Bacterial strains and study group
A total of 148 strains corresponding to 142 patients were included: 95 strains isolated from
respiratory specimens (89 tracheal aspirates, 4 sputa, 1 pleural fluid and 1 protected specimen
brush) from 93 patients with clinical suspicion of LRTI, 35 strains from nasal swab samples,
corresponding to nasal carriers and 18 strains isolated from blood cultures.
Agr activity in respiratory derived S.aureus isolates
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Of the total of 148 strains included in this study, 25 (16.9%) were methicillin-resistant S.
aureus (MRSA) and 123 (83.1%) were methicillin-sensitive S. aureus (MSSA) (Table 1), with
11 (8.9%) of the 142 patients designated as previous MRSA carriers. From the 111 patients pre-
senting infection (either LRTI or bacteraemia), the origin was nosocomial (84.7%), community
acquired (12.6%), and health care associated (2.7%).
High clonal complex (CC) diversity was observed among isolates included in the study. For
MSSA isolates, the most frequent CCs were CC30 (22%), CC5 (17.9%) and CC45 (17.1%),
whereas for MRSA isolates, CC5 (72%) was the most frequent, followed by CC22 (16%). Previ-
ous studies have highlighted that CC5 is the most frequent MRSA clonal type in Spain [37].
Measuring Agr activity: CAMP versus VLT
The 148 isolates representing the three study groups [LTRI (n = 95), nasal carriage (n = 35)
and bacteraemia (n = 18)] were assayed using both the classical CAMP assay and VLT (S1
Table), where Agr functionality was observed in 118 and 125 strains (79.7% and 84.5%) respec-
tively. Table 1 shows the percentages of MRSA, Agr functionality and distribution of Agr
alleles, in the different study groups. Concordance between both phenotypic Agr tests was
85.8% (127/148) (κ: 0.519; SE: 0.091) (Table 2). Each sample group was analysed separately: in
the LRTIs group, Agr activity was functional in 77 (81.1%) and 79 (83.2%) strains using the
Agr CAMP assay and VLT, respectively. Concordance between both tests was 85.2% (81/95)
(κ: 0.499; SE: 0.116). Results from the nasal carriage group showed that Agr was functional in
28 (80%) and 29 (82.9%) strains using the Agr CAMP assay and VLT, respectively. Concor-
dance between both tests was 91.4% (32/35) (κ: 0.717; SE: 0.153). Results from the bacteraemia
group highlighted that Agr was functional in 13 and 17 strains (72.2% and 94.4%), respectively.
Concordance between both tests was 77.7% (14/18) (κ: 0.265; SE: 0.220).
Discordant cases VLT vs. CAMP assay
As shown in Table 2, a total of 21 strains presented a discordant result between both tests;
LTRIs n = 14, nasal carriage n = 3, bacteraemia n = 4. Of the 21 strains with discordant results,
7 strains exhibited synergy between delta-, alpha- and beta- haemolysins on blood agar plates,
and were considered as positive by the CAMP assay according to Traber et al [17]. However,
for these strains low fluorescence intensity comparable to the negative control was observed,
therefore, they were classified as negative by the VLT test. In the remaining 14 strains, the pat-
tern of haemolysis on the SBA corresponded to an exclusive presence of beta haemolysis for 6
strains, and lack of haemolysis for 8 strains, therefore they were considered as negative by the
CAMP assay. However, for these strains an increased fluorescence was measured, therefore
they were classified as positive by the VLT test. To accurately determine the Agr functionality
in the discordant cases, we measured the level of expression of RNAIII by real time quantita-
tive reverse transcriptase -PCR (Real time qRT-PCR) (Table 3, S1 Fig). Of the 21 discordant
strains, according to CAMP assay and RNAIII expression, a functional Agr was observed in 7
(33.3%) and 11 (52.4%) strains, respectively. Concordance between both tests was 23.8%
Table 2. Concordance between VLT test and CAMP assay results.
CAMP Assay result VLT result
Positive (%) Negative (%) Total (%)
Positive (%) 111 (94.1) 7 (5.9) 118 (79.7)
Negative (%) 14 (46.7) 16 (53.3) 30 (20.3)
Total (%) 125 (84.4) 23 (15.6) 148 (100)
https://doi.org/10.1371/journal.pone.0175552.t002
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(5/21) (κ: -0.5; SE: 0.183). According to VLT and RNAIII expression, a functional Agr was
observed in 14 (66.7%) and 11 (52.4%) strains respectively, with a concordance between both
tests of 76.2% (16/21) (κ: 0.516; SE: 0.18).
Correlation between Agr functionality and phenotypical and genotypical
variables
Agr activity, determined through CAMP, VLT and qRT-PCR, was positive in 122 (82.4%) of
the isolates (n = 148) examined. 72% of MRSA and 84.5% of MSSA isolates were Agr positive.
Agr function and study groups were analysed separately. Among the 95 strains from respira-
tory samples, Agr was functional in 78 cases (82.1%). 22 (23.2%) out of the 95 strains were
MRSA whereas 73 (76.8%) were MSSA. Regarding the 35 strains from nasal carriers, Agr was
functional in 29 (82.9%) cases. 2 (5.7%) out of the 35 strains were MRSA and 33 (94.3%) were
MSSA. Among the 18 strains isolated from patients with bacteraemia, Agr was functional in 15
(83.3%). One (5.6%) strain of this group was MRSA whereas 17 (94.4%) were MSSA.
We investigated potential associations between Agr functionality and the Agr allele. The
most frequent group Agr allele group in the LRTIs group was AgrI (43.2%), followed by AgrII
(42.1%), AgrIII (11.6%), and AgrIV (3.2%). For the strains isolated from nasal carriers, the
AgrIII (42.9%) was the most frequent, followed by AgrI (37.1%) and AgrII (20%). Agr group
distribution of the strains isolated from bacteraemia were both Agr I and Agr III (38.9%) and
Table 3. Description of discordant cases between VLT and Agr CAMP, including haemolysin pattern, RNA III, Agr allele and clonal complex.
Study group (n)
Isolate ID
VLT
result
Agr CAMP
result
Agr CAMP assay
(haemolysin)
RNAIII
expression
Agr
allele
Clonal Complex
Pneumonia (2)
S19
S116
Negative
Negative
Positive
Positive
Alpha and delta
Alpha and delta
Negative
Negative
II
II
CC5 /ST5-MRSA-I
CC1(ST573/772-MSSA)
Tracheobronchitis (8)
S1
S12
S28
S44
S50
S55
S124
S132
Negative
Negative
Positive
Positive
Negative
Positive
Positive
Positive
Positive
Positive
Negative
Negative
Positive
Negative
Negative
Negative
Alpha and delta
Alpha and delta
Beta
Beta
Alpha and delta
No hemolysin
No hemolysin
Beta
Negative
Negative
Positive
Positive
Negative
Negative
Positive
Positive
I
I
I
III
I
III
II
II
CC8-MRSA-IV [sea+], Lyon Clone/
UK-EMRSA-2
CC22-MSSA
CC45-MSSA
CC30-MSSA
CC398-MSSA [PVL+]
CC30-MSSA
CC5-MRSA-IV, Paediatric clone
CC15-MSSA
Bronchial Colonization
(3)
S71
S145
S186
Positive
Negative
Positive
Negative
Positive
Negative
Beta
Alpha and delta
No hemolysin
Positive
Negative
Positive
II
II
III
CC5-MSSA
CC5-MSSA
CC30-MSSA
Others LRTI (1)
S135 Positive Negative No hemolysin Positive II CC5-MRSA-IV&VI
Carriage (3)
S38
S39
S140
Positive
Positive
Negative
Negative
Negative
Positive
No hemolysin
No hemolysin
Alpha and delta
Positive
Negative
Positive
III
III
II
CC30-MSSA
CC30-MSSA
CC5-MSSA
Bacteraemia (4)
S4077
S4124
S4171
S4172
Positive
Positive
Positive
Positive
Negative
Negative
Negative
Negative
No hemolysin
No hemolysin
Beta
Beta
Positive
Negative
Negative
Positive
II
II
III
I
CC15-MSSA
CC5-MSSA
CC30-MSSA
CC8-MSSA-SCCfus
https://doi.org/10.1371/journal.pone.0175552.t003
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AgrII (22.2%) (Table 1). No statistically significant association was found between Agr func-
tionality and Agr allele (Table 4).
When analysing together strains from the three study groups no statistical significant corre-
lations were observed between the Agr function and methicillin resistance, clonal complex, the
Agr allele, or the presence of genes encoding virulence factors. When groups analysed sepa-
rately a significant association between Agr function and sensitivity to cloxacillin was observed
in the nasal carriers (p = 0.025). However, this is most likely biased by the low sample number
in this group (Table 4).
Correlation between Agr functionality and clinical variables
Of the 93 patients presenting LRTI, 10 (10.8%) of them were previous MRSA carriers. Persis-
tent isolation despite adjusted antibiotic treatment was observed in 41 (45.1%) patients. Pres-
ence of respiratory complication was documented in 18 cases (19.6%). Among the 18 patients,
5 (5.4%) fatal cases were related to respiratory infection. No statistically significant correlations
were observed neither between Agr functionality and persistent isolation nor between Agr
Table 4. Correlation between Agr functionality determined through CAMP, VLT and qRT-PCR and genotypic characteristics, defined as presence
(Pos) or absence (Neg) of specific virulence factor gene probes.
Array gene
probes
LRTI (n = 95) Carriage (n = 35) Bacteraemia (n = 18)
Agr functionality Agr functionality Agr functionality
Positive, n
(%)
Negative, n
(%)
p-value Positive, n
(%)
Negative, n
(%)
p-value Positive, n
(%)
Negative, n
(%)
p-value
mecA Pos 16 (76.2) 5(23.8) 0.519 0 (0) 2 (33.3) 0.025* 1 (6.7) 0 (0) 1
Neg 62 (83.8) 12 (16.2) 29 (87.9) 4 (12.1) 14 (82.4) 3 (17.6)
sarA Pos 77 (81.9) 17 (18.1) 1 29 (82.9) 6 (17.1) N/A 15 (83.3) 3 (16.7) N/A
Neg 1 (100) 0 (0) - - 0 (0) 0 (0)
saka Pos 58 (81.7) 13 (18.3) 0.084 24 (82.8) 5 (17.2) 1 13 (81.3) 3 (18.8) 1
Neg 20 (87) 3 (13) 5 (83.3) 1 (16.7) 2 (100) 0 (0)
lukS/F-PVL Pos 0 (0) 1 (100) 0.169 - - N/A 1 (100) 0 (0) 1
Neg 78 (83) 16 (17) 29 (82.9) 6 (17.1) 14 (82.4) 3 (17.6)
chpa Pos 59 (84.3) 11 (15.7) 0.530 22 (81.5) 5 (18.5) 1 12 (80) 3 (20) 0.558
Neg 18 (75) 6 (25) 7 (87.5) 1 (12.5) 3 (100) 0 (0)
scn Pos 71 (83.5) 14 (16.5) 0.253 26 (83.9) 5 (16.1) 0.546 14 (82.4) 3 (17.6) 0.833
Neg 7 (70) 3 (30) 3 (75) 1 (25) 1 (100) 0 (0)
tst1b Pos 13 (76.5) 4 (23.5) 0.497 12 (80) 3 (20) 0.853 4 (80) 1 (20) 0.650
Neg 65 (83.3) 13 (16.7) 16 (84.2) 3 (15.8) 11(84.6) 2 (15.4)
Agr allele I 33 (80.5) 8 (19.5) 0.254 12(41.4) 1 (16.7) 0.461 6 (85.7) 1 (14.3) 0.879
II 35 (87.5)) 5 (12.5) 5 (17.2) 2 (33.3) 3 (75) 1 (25)
III 7 (63.6) 4 (36.4) 12 (41.4) 3 (50) 6 (85.7) 1 (14.3)
IV 3 (100) 0 (0) - - 0 (0) 0 (0)
LRTI: lower respiratory tract infection, including pneumonia, tracheobronchitis, bronchial colonization, pneumonitis, bronchoaspiration pneumonia and
tracheostomy infection.
agr: accessory gene regulator, sarA: staphylococcal accessory regulator A, mecA: penicillin binding protein 2A, lukS/F-PVL: Panton Valentine leukocidin,
chp: chemotaxis inhibiting protein, scn: staphylococcal complement inhibitor, tst1: toxic shock syndrome toxin 1, N/A: not applicable
All comparisons were done for each study group.
aFor one strain from LRTI group an ambiguous result was obtained for the corresponding probes in the StaphyType DNA microarray.
bFor one strain from carriers group an ambiguous result was obtained for the corresponding probe in the StaphyType DNA microarray.
* p< 0.05
https://doi.org/10.1371/journal.pone.0175552.t004
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functionality and presence of respiratory complications and death. Among the 18 patients pre-
senting bacteraemia, in 3 (16.7%) cases, positive blood culture was obtained after 72 hours.
Eight (44.4%) cases developed complications: 4 patients (22.2%) presented septic metastasis
and 4 patients (22.2%) presented shock. No statistically significant correlations were observed
between Agr functionality and persistent blood culture after 72h, and the development of
complication and/or death as shown in Table 5. No statistically significant associations were
observed when a multivariate analysis was adopted to investigate the relationship between Agr
function and clinical or microbiological variables.
Discussion
The objective of this study was to evaluate the activity of Agr in S. aureus clinical isolates
derived from lower respiratory tract, and to investigate correlations between the Agr function-
ality and the clinical and microbiological variables according to the different study groups.
Our results illustrate a high percentage (82.1%) of LRTI isolates were Agr functional. This is in
agreement with Chaffin et al, who observed hld and psm gene upregulation in a mouse model
of pneumonia [38]. Furthermore, virulence genes regulated by Agr have an important function
in escape from alveolar macrophages [39, 40] and neutrophils [41], both cells comprising the
first line of defence in lung infections. Other groups have highlighted that Agr dysfunction is
associated with persistent bacteraemia and that during growth in blood, apolipoproteins can
interfere and inhibit quorum sensing and Agr activity [42]. Additionally, downregulating tox-
icity has been observed to positively influence fitness of S. aureus when grown in media supple-
mented with human serum [43] presumably as a trade- off to offset energetically costly toxin
production in the face of a challenging environment. Recently, Painter et al reviewed numer-
ous studies and concluded that strains isolated from bacteraemia displayed Agr dysfunction in
3–82% of cases [21]. This large variation may be due to differences in Agr functionality testing,
isolate lineage and patient control groups. Agr dysfunction was not associated with bacterae-
mia strains in our study, where dysfunction was observed in 16.7% of cases.
Previous studies have questioned the sensitivity of the CAMP assay at determining Agr
function [31]. Additionally, the interpretation of synergistic haemolysis can be subjective and
results may vary between different laboratories, especially for clinical isolates with weak hae-
molytic activity [17]. To accommodate for these observations, Agr functionality was examined
using both the CAMP assay and the VLT, a highly sensitive assay specific to toxins strictly reg-
ulated by Agr [31], with discordant strains measured by gold-standard qRT-PCR. Our results
report a higher concordance between qRT-PCR and VLT than for CAMP assay.
There are some fundamental differences between these methods that need to be considered
when evaluating Agr functionality. VLT has been shown to be highly sensitive to μM
Table 5. Correlation between Agr functionality and clinical variables.
Clinical variables LRTI (n = 93)a Bacteraemia (n = 18)
Agr functionality Agr functionality
Positive, n (%) Negative, n (%) p-value Positive, n (%) Negative, n (%) p-value
Persistent isolation after 72hb No 41 (82) 9 (18) 1 13 (86.7) 2 (13.3) 0.442
Yes 34 (82.9) 7 (17.1) 2 (66.7) 1 (33.3)
Development of complications/mortality No 59 (79.7) 15 (20.3) 0.509 8 (80) 2 (20) 1
Yes 16 (88.9) 2 (11.1) 7 (87.5) 1 (12.5)
aFor the 93 patients in the LRTI group, persistent isolation after 72h was not considered for two cases, as these patients did not receive antibiotic treatment.
b Persistent isolation after 72h despite adjusted antimicrobial treatment
https://doi.org/10.1371/journal.pone.0175552.t005
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concentrations of specific Agr-regulated delta and PSMα1–4 toxins [31], a level of sensitivity
which may not be achieved using CAMP assay, resulting in more isolates reported as Agr func-
tional. The VLT is performed using harvested culture supernatant following aerobic growth in
liquid broth, whereas the CAMP assay is performed under static conditions using solid agar.
The difference in culture conditions may influence Agr functionality as differences in aerobic
culture conditions are known to induce differential virulence gene expression [44, 45]. Addi-
tionally, the diffusion of toxins through blood agar may be less efficient at lysing cells than the
interaction of toxins with vesicular lipid membranes, possibly influencing Agr functionality
measurements.
To evaluate Agr function in discordant strains we investigated the expression of RNAIII, a
surrogate marker of Agr function by qRT-PCR. RNA was extracted and prepared during late
exponential to early stationary phase of growth (6h) where RNAIII expression is maximal [6].
Previous studies have highlighted that late transcription of RNAIII is associated with failure to
translate δ- and α- haemolysin resulting in Agr dysfunction [17, 29]. Therefore, this may
explain those strains that are designated Agr dysfunctional by CAMP assay but Agr functional
by RNAIII measurements, as CAMP assay is dependent on synergistic haemolysis driven by
toxin expression. Four strains were designated Agr functional by VLT but dysfunctional by
RNAIII measurement. Recent work has shown RNAIII-independent expression of PSM toxins
via AgrA binding directly to psm promoter [46, 47]. This may explain the above results how-
ever further work is required to fully validate this claim.
Given the importance of Agr in virulence factors expression, we investigated whether Agr
function was associated with persistent respiratory isolation or complications and persistent
bacteraemia. No statistical significant associations where observed in either scenario, however
other factors other than Agr function may be important in persistence. S. aureus small colony
variants (SCV) represent a slow growing sub-population associated with chronic, persistent
and relapsing infections [48]. SCVs are phenotypically distinct, displaying reduced pigmenta-
tion, haemolysis and increased invasiveness and persistence intracellularly [48]. Recent work
has observed that SCV have a rapid reversion rate when grown under laboratory culture con-
ditions and switch to wild type phenotype upon primary culture from clinical samples [49]
which may contribute to the lack of microbial factors observed in this study associated with
isolates derived from persistent infections.
The importance of correctly confirming Agr functionality of a clinical isolate is
highlighted by the importance of Agr for virulence in numerous animal models and associa-
tions with clinical observations. This work shows that for the majority of strains a high
concordance was observed between CAMP and VLT; however, caution must be used to
determine strains that are truly Agr functional/dysfunctional. Although the CAMP assay is
the most routinely used to determine Agr functionality, there are pitfalls in terms of accurate
measurement, ambiguous results and the impact of delayed RNAIII transcription. Higher
concordance was observed between VLT and RNAIII measurements, however the high sensi-
tivity of the VLT assay may wrongly identify Agr dysfunctional strains as functional. There-
fore, we propose that a combination of phenotypic and genotypic assays must be used to
accurately determine the functionality of Agr and should be used in future experiments des-
ignated to investigate associations between clinical outcome or antibiotic susceptibility and
Agr function. Using a combination approach would also help to define those isolates that are
completely Agr inactive (VLT negative) and those that may have low or delayed Agr activity
(CAMP and RNAIII negative). The results exhibited in this study include for the first time,
the analysis of Agr function in strains isolated from samples from patients with respiratory
infections. However, further studies are required to determine whether the functionality of
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the Agr system can be a marker of pathogenicity for strains isolated from respiratory tract
infection and whether this has an influence on the clinical outcome.
It is worth to mention that our cohort does not include severe necrotizing pneumonia
cases, uncommon in our geographical region. On the other hand, persistence in the respiratory
tract is not associated to unfavourable outcome as it is in bacteremia, but more to an adapta-
tion to the niche [50]. Multicentric studies are already taking place in the context of the New
Drugs for Bad Bugs programme, an Innovative Medicines Initiative including multiple vari-
ables (https://clinicaltrials.gov/ct2/show/NCT02413242) and will help to elucidate the real
importance of bacterial molecular determinants in LRTI.
Supporting information
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